Quest Diagnostics put up a definitive beat Thursday, driven by solid demand across its consumer division.
Quest Diagnostics Surges After Hims- And Oura-Tied Beat
Licensing
10:09 AM ET 07/23/2026
Quest Diagnostics (DGX) put up a definitive second-quarter beat Thursday, driven by solid demand across its consumer division, leading the stock to retake its buy point. The company is a well-known lab testing outfit. It provides diagnostic testing for employers and medical providers. The direct-to-consumer lab testing business is also getting newfound attention after Quest inked deals with Hims &…
Quest Diagnostics Stock Hits 52-Week High - Here's Why - Quest Diagnostics (NYSE:DGX)
Lockheed Martin, Quest Diagnostics, Thermo Fisher Scientific And Other Big Stocks Moving Higher On Thursd
Dr Lal Path Labs shares soar 8% after Q1 earnings beat estimates. What Nomura, Nuvama, other brokerages are saying?
Domino's Pizza Q2 'A Trough,' Outlook 'Isn't Spectacular': Analysts - Domino's Pizza (NASDAQ:DPZ)
Domino's CEO Says Growth Story Is 'As Strong As Ever' - Domino's Pizza (NASDAQ:DPZ)
Laurus Labs shares rally over 4% as Q1FY27 profit jumps 126% on strong CDMO growth
